Skip to content
Open access · OA via Europe PMC

The Development of Cellular Aging Models Based on AD-MSCs.

Elizova NV, Zhivodernikov IV, Vasilyev VS, Tolkachev YD, Markina YV, Markin AM, Kirichenko TV.

Cells · 2026

Abstract

Cellular senescence(definition) of adipose tissue-derived mesenchymal stromal cells (AD-MSCs) is associated with chronic low-grade inflammation, metabolic dysfunction, and impaired adipogenesis contributing to the development of obesity, insulin resistance, and the progression of age-associated diseases. The aim of this study was to develop a model of cellular aging based on AD-MSCs to study the senolytic efficacy of the natural fisetin preparation for the subsequent development of geroprotective therapeutic strategies. The senescent markers SA-β-gal, SASP factors, and cell cycle arrest markers p16, p21, and p53 were assessed in models of replicative and stress-induced aging of AD-MSCs. H<sub>2</sub>O<sub>2</sub> was identified as the most effective inducer of AD-MSC cellular senescence in comparison with LPS. It has been shown in the model of H<sub>2</sub>O<sub>2</sub>-induced senescence of AD-MSCs that the proportion of SA-β-gal+ cells was 2.0 (0.7)% in non-stimulated AD-MSCs, 81.7 (12.1)% in H<sub>2</sub>O<sub>2</sub>-stimulated AD-MSCs, and 19.1 (5.2)% and 13.0 (3.2)% after short-term (24 h) and long-term (7 days) fisetin treatment, respectively, indicating that fisetin treatment was associated with a lower proportion of SA-β-gal+ cells. Fisetin treatment resulted in a statistically significant decrease in the secretion of MCP-1, especially during long-term incubation. IL-1β showed a significant decrease after 7 days of fisetin treatment compared to H<sub>2</sub>O<sub>2</sub>, but the effect at 24 h was only significant in the group of 7 days of fisetin treatment. Fisetin treatment was also associated with higher p53 and p21 concentrations. Thus, in the present study, a model of H<sub>2</sub>O<sub>2</sub>-induced cellular senescence of AD-MSCs was developed, which can be used to evaluate the geroprotective potential of senotherapeutic preparations; fisetin warrants further evaluation as a potential senotherapeutic agent in this model.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3390/cells15181634
Canonical
link ↗
Fetched
2026-10-06 MST

Cite this

APA
NV, E., IV, Z., VS, V., YD, T., YV, M., AM, M., &amp; TV., K. (2026). The Development of Cellular Aging Models Based on AD-MSCs. <em>Cells</em>. https://doi.org/10.3390/cells15181634
Vancouver
NV E, IV Z, VS V, YD T, YV M, AM M, et al. The Development of Cellular Aging Models Based on AD-MSCs. Cells. 2026. doi:10.3390/cells15181634.
BibTeX
@article{elizova2026TheDev, title = {The Development of Cellular Aging Models Based on AD-MSCs.}, author = {Elizova NV and Zhivodernikov IV and Vasilyev VS and Tolkachev YD and Markina YV and Markin AM and Kirichenko TV.}, journal = {Cells}, year = {2026}, doi = {10.3390/cells15181634}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings